Altesa

Altesa is a clinical-stage biopharmaceutical company focused on developing innovative antiviral treatments aimed at addressing significant global health threats posed by high-consequence viral pathogens. The company specializes in creating novel antiviral drugs to combat common respiratory viruses and other diseases of global importance, including those responsible for dengue fever, yellow fever, Zika virus, and Powassan virus. Altesa's research aims to enable healthcare providers to prevent acute exacerbations of chronic conditions, such as chronic obstructive pulmonary disease (COPD), linked to rhinovirus infections. Through its efforts, Altesa seeks to contribute to improved health outcomes and enhanced disease management.